Depreciation of NORTHWEST BIOTHERAPEUTICS INC from 30 Sep 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NORTHWEST BIOTHERAPEUTICS INC annual and quarterly Depreciation in USD history and change rate from 30 Sep 2014 to 31 Dec 2024.
  • NORTHWEST BIOTHERAPEUTICS INC Depreciation for the quarter ending 31 Mar 2024 was $400,000, a 33% increase year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC annual Depreciation for 2024 was $1,700,000, a 13% increase from 2023.
  • NORTHWEST BIOTHERAPEUTICS INC annual Depreciation for 2023 was $1,500,000, a 15% increase from 2022.
  • NORTHWEST BIOTHERAPEUTICS INC annual Depreciation for 2022 was $1,300,000, a 333% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

NORTHWEST BIOTHERAPEUTICS INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,700,000 +$200,000 +13% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $1,500,000 +$200,000 +15% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $1,300,000 +$1,000,000 +333% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $300,000 +$213,000 +245% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $87,000 +$66,000 +314% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $21,000 -$1,279,000 -98% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $1,300,000 +$900,000 +225% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $400,000 +$211,000 +112% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2019 2018 FY
2016 $189,000 +$133,000 +238% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
2015 $56,000 +$44,000 +367% 01 Jan 2015 31 Dec 2015 10-K 17 Apr 2017 2016 FY
2014 $12,000 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2016 2015 FY

NORTHWEST BIOTHERAPEUTICS INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $400,000 +$100,000 +33% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q1 2023 $300,000 +$200,000 +200% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $100,000 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2020 $87,000 $54,000 +$49,000 +980% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $38,000 $17,000 +$9,000 +112% 01 Jul 2020 30 Sep 2020 10-Q 15 Jan 2021 2020 Q3
Q2 2020 $29,000 $2,000 -$4,000 -67% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $33,000 $14,000 +$12,000 +600% 01 Jan 2020 31 Mar 2020 10-Q 24 Jun 2020 2020 Q1
Q4 2019 $21,000 $5,000 -$232,000 -98% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $253,000 $8,000 -$333,000 -98% 01 Jul 2019 30 Sep 2019 10-Q 15 Jan 2021 2020 Q3
Q2 2019 $586,000 $6,000 -$351,000 -98% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $937,000 $2,000 -$363,000 -99% 01 Jan 2019 31 Mar 2019 10-Q 24 Jun 2020 2020 Q1
Q4 2018 $1,300,000 $237,000 -$22,000 -8.5% 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 $1,322,000 $341,000 +$300,000 +732% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,022,000 $357,000 +$313,000 +711% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $709,000 $365,000 +$309,000 +552% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $400,000 $259,000 +$205,000 +380% 01 Oct 2017 31 Dec 2017 10-K 02 Apr 2019 2018 FY
Q3 2017 $195,000 $41,000 -$14,000 -25% 01 Jul 2017 30 Sep 2017 10-Q 16 Nov 2018 2018 Q3
Q2 2017 $209,000 $44,000 -$23,000 -34% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $232,000 $56,000 +$43,000 +331% 01 Jan 2017 31 Mar 2017 10-Q 16 May 2018 2018 Q1
Q4 2016 $189,000 $54,000 +$42,000 +350% 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $147,000 $55,000 +$26,000 +90% 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017 2017 Q3
Q2 2016 $121,000 $67,000 +$55,000 +458% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $66,000 $13,000 +$10,000 +333% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $56,000 $12,000 01 Oct 2015 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q3 2015 $29,000 -$317,000 -92% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $12,000 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $3,000 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q3 2014 $346,000 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.